EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
18 hedge funds and large institutions have $251K invested in eFFECTOR Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
18
Holding in Top 10
–
Calls
$106K
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$17.9K | |
| 3 | +$6K | |
| 4 |
Jane Street
New York
|
+$5.42K |
| 5 |
VF
Virtu Financial
New York
|
+$5K |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$1.91M | |
| 3 | -$1.37M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$474K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$178K |